(Q46426412)

22 December 2017

title

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience (English)

1 reference

22 December 2017

0 references

1 reference

Maricer P Escalón

1

1 reference

22 December 2017

Nina S Liu

2

1 reference

22 December 2017

Ying Yang

3

1 reference

22 December 2017

Mark Hess

4

1 reference

22 December 2017

Pamela L Walker

5

1 reference

22 December 2017

Terry L Smith

6

1 reference

22 December 2017

Nam H Dang

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

published in

Cancer

1 reference

22 December 2017

volume

103

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

2091-2098

1 reference

22 December 2017

Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20999

7 January 2021

Identifiers

DOI

10.1002/CNCR.20999

1 reference

22 December 2017

PubMed ID

15816054

1 reference

22 December 2017